AstraZeneca&#39;s Crestor May Harm Kidneys
100059
Twenty-nine patients who took AstraZeneca Plc&#39;s AZN.L AZN.N anti-cholesterol drug Crestor have developed kidney damage, a US consumer group said on Friday as it called again for a ban on the medicine.
75561
Agency says painkillers, such as Alleve and Naprosyn, can cause an increased risk of heart problems. WASHINGTON  - The US Food and Drug Administration on Monday issued a warning to patients taking
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
179939
AstraZeneca&#39;s newest advertisements for its cholesterol-lowering drug Crestor are misleading and should be pulled from the market, consumer group Public Citizen says.
353921
Twenty-nine patients who took  AstraZeneca Plc's AZN.L AZN.N anti-cholesterol drug Crestor  have developed kidney damage, a U.S. consumer group said on  Friday as it called again for a ban on the medicine.
180591
Shares of AstraZeneca Plc and GlaxoSmithKline Plc, the UK&#39;s two biggest drugmakers, fell after a US health official said two of their best-selling treatments need closer safety reviews.
266346
A newspaper advertisement for  AstraZeneca Plc's cholesterol drug Crestor that touts patient  safety is misleading and should no longer be published,  regulators warned in a letter released on Wednesday.
191874
Shares in AstraZeneca Plc fell as much as 10 percent on Friday after regulators in the United States and Europe raised safety concerns about the Anglo-Swedish drug maker&#39;s anti-cholesterol treatment Crestor.
149001
AstraZeneca today that CRESTORâ¢ (rosuvastatin), its statin indicated for the treatment of dislipidaemia, has reached the significant milestone of 10 million prescriptions worldwide.
132323
The new warning states that Bextra should not be used in patients undergoing heart bypass surgery. In October, Bextra&#39;s manufacturer, Pfizer, announced results of a study showing an increase in heart problems in patients having heart bypass surgery.
629073
Shire Pharmaceuticals has won US regulatory approval for its long-delayed Fosrenol treatment for severe kidney disease. Fosrenol is Shire&#39;s SHP.
272511
Another blockbuster painkiller, Celebrex, has been found to raise the risk of heart attacks when taken in high doses, the drug&#39;s maker said yesterday.
333434
The diabetes drug Actos cuts the risk of heart attack, stroke and death but raises the risk of heart failure, according to one study published on Tuesday, while a second confirmed disputed findings that rival Avandia raises heart risks.
726448
AstraZeneca Plc&#39;s cholesterol-lowering drug Crestor performed better than Pfizer Inc&#39;s Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
542397
AstraZeneca Plc's cholesterol-lowering drug Crestor has been linked to the death of a patient, Europe's third largest drugmaker said on Monday.